T. Rowe Price Investment Management, Inc.
Position in CYTK — Cytokinetics Inc
CIK 1897612
BALTIMORE, MD
Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,594,628,844
+$439,632,550 QoQ
Shares Held
18,718,498
+6.8% QoQ
Ownership
13.5%
of shares outstanding
% of Portfolio
1.05%
of 13F equity value
Holder Rank
#2
of 480 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026T. Rowe Price Investment Management, Inc. holds $12,244,164,567 across 51 Biotechnology names. CYTK ranks #3 (13.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
6,754,846 | $1,801,652,525 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,642,173 | $1,698,463,338 | |
| 3 | CYTK |
Cytokinetics Inc
This page
|
18,718,498 | $1,594,628,844 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
6,257,261 | $717,520,118 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
12,207,450 | $709,619,068 | |
| 6 | DYN |
Dyne Therapeutics, Inc.
|
30,912,287 | $686,561,894 | |
| 7 | CGON |
CG Oncology, Inc.
|
6,616,899 | $470,130,673 | |
| 8 | IMNM |
Immunome Inc.
|
19,676,883 | $416,953,150 |
All Filings in CYTK
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,594,628,844 | 18,718,498 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,154,996,294 | 17,523,840 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $596,666,270 | 9,390,404 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,048,664,060 | 19,080,496 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $581,584,617 | 17,602,440 | Shares | Sole | 2025-08-14 | |
| 2025-04-30 | $574,918,968 | 13,420,144 | Shares | Sole | 2025-05-07 | |
| 2025-03-31 | $400,101,537 | 9,955,251 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $505,779,865 | 10,752,123 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $511,631,313 | 9,689,987 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $440,953,519 | 8,138,677 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $359,074,604 | 5,121,589 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $186,139,702 | 2,229,485 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $53,504,839 | 1,816,186 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $58,856,787 | 1,804,316 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $53,420,601 | 1,518,062 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $21,244,259 | 463,646 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||